Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 2.2x - 2.4x | 2.3x |
| Selected Fwd Ps Multiple | 1.9x - 2.1x | 2.0x |
| Fair Value | €0.038 - €0.043 | €0.041 |
| Upside | 45.3% - 60.6% | 52.9% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Diaceutics PLC | - | AIM:DXRX |
| Physiomics Plc | - | AIM:PYC |
| genedrive plc | - | AIM:GDR |
| Oxford BioDynamics Plc | - | AIM:OBD |
| IXICO plc | - | AIM:IXI |
| Proteome Sciences plc | - | DB:PI2 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| DXRX | PYC | GDR | OBD | IXI | PI2 | |||
| AIM:DXRX | AIM:PYC | AIM:GDR | AIM:OBD | AIM:IXI | DB:PI2 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 19.1% | -6.1% | -26.7% | -6.9% | -5.3% | 1.0% | ||
| 3Y CAGR | 32.1% | -7.9% | -10.0% | 23.1% | -14.4% | -1.6% | ||
| Latest Twelve Months | 35.7% | -15.5% | 125.4% | 45.2% | 7.3% | -2.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 0.3% | -49.4% | -3177.5% | -2143.6% | -3.5% | -14.4% | ||
| Prior Fiscal Year | -7.4% | -78.8% | -9363.6% | -2122.7% | -17.7% | -48.6% | ||
| Latest Fiscal Year | -5.3% | -106.8% | -1412.2% | -1818.7% | -34.7% | -69.7% | ||
| Latest Twelve Months | -5.3% | -116.9% | -1201.5% | -1405.5% | -24.0% | -69.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 183.3x | -1.4x | -1.0x | -1.0x | -6.1x | -10.2x | ||
| Price / LTM Sales | 3.5x | 2.2x | 12.0x | 11.5x | 2.0x | 1.8x | ||
| LTM P/E Ratio | -66.3x | -1.9x | -1.0x | -0.8x | -8.3x | -2.6x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 2.0x | 3.5x | 12.0x | |||||
| Historical LTM P/S Ratio | 1.5x | 2.1x | 3.0x | |||||
| Selected Price / Sales Multiple | 2.2x | 2.3x | 2.4x | |||||
| (x) LTM Sales | 5 | 5 | 5 | |||||
| (=) Equity Value | 11 | 11 | 12 | |||||
| (/) Shares Outstanding | 295.2 | 295.2 | 295.2 | |||||
| Implied Value Range | 0.04 | 0.04 | 0.04 | |||||
| FX Rate: GBP/EUR | 0.9 | 0.9 | 0.9 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.04 | 0.04 | 0.05 | 0.03 | ||||
| Upside / (Downside) | 54.6% | 62.7% | 70.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DXRX | PYC | GDR | OBD | IXI | PI2 | |
| Value of Common Equity | 113 | 1 | 7 | 11 | 12 | 7 | |
| (/) Shares Outstanding | 84.5 | 303.2 | 624.9 | 1,957.6 | 92.7 | 295.2 | |
| Implied Stock Price | 1.34 | 0.00 | 0.01 | 0.01 | 0.13 | 0.02 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.87 | |
| Implied Stock Price (Trading Cur) | 1.34 | 0.00 | 0.01 | 0.01 | 0.13 | 0.03 | |
| Trading Currency | GBP | GBP | GBP | GBP | GBP | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.87 | |